First description of abdominal infection due to Alistipes onderdonkii

Cobo, Fernando; Foronda, Carla; Pérez-Carrasco, Virginia; Martín-Hita, Lina; García‐Salcedo, José A.; Navarro-Marí, José María

doi:10.1016/j.anaerobe.2020.102283

Cited by 14 publications

(13 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 74 , 75 Other bacteria in Figure 3 that could cause infection in humans, such as Brevibacterium , Alistipes , Prevotella , Anaerotruncus , and Veillonella , are rare. 76 , 77 , 78 , 79 , 80 , 81 In our study, most of the abovementioned bacteria in this paragraph were significantly increased in the PD group compared to HC in the included studies, except Brevibacterium , Bacteroides , and Haemophilus . Evidence suggests that there are systemic immuno‐inflammatory processes in PD that could be related to an abnormal increase in putative pathobionts.…”

Section: Discussionsupporting

confidence: 48%

“…74,75 Other bacteria in Figure 3 that could cause infection in humans, such as Brevibacterium, Alistipes, Prevotella, Anaerotruncus, and Veillonella, are rare. [76][77][78][79][80][81] In our study, most of the abovementioned bacteria in this paragraph were significantly increased in the PD group compared to HC in the included studies, except Brevibacterium, Bacteroides, and…”

Section: Ta B L E 2 (Continued)supporting

confidence: 47%

See 1 more Smart Citation

Gut bacterial profiles in Parkinson's disease: A systematic review

Liang

et al. 2022

CNS Neurosci Ther

View full text Add to dashboard Cite

Introduction:Recent advances have highlighted the relationships between gut dysbiosis and Parkinson's disease (PD). Microbiota transplantation from PD patients to mice can induce increased alpha-synuclein-mediated motor deficits. Human studies have identified differences in the gut microbiota of PD patients compared to healthy controls. We undertook a systematic review to evaluate the available evidence for the involvement of gut bacteria in the etiology of PD. Methods:The PubMed databank, the China National Knowledge Infrastructure databank, and Wanfang Data were searched from inception until June 2021 to identify human case-control studies that investigated relationships between PD and microbiota quantified from feces. We evaluated the resulting studies focusing on bacterial taxa that were different between PD patients and healthy controls.Results: Twenty-six studies were found in which 53 microbial families and 98 genera exhibited differences between patients with PD and healthy controls. The genera identified by more than two studies as increased in PD were Bifidobacterium, Alistipes,

show abstract

Section: Discussionsupporting

confidence: 48%

Section: Ta B L E 2 (Continued)supporting

confidence: 47%

Gut bacterial profiles in Parkinson's disease: A systematic review

Liang

et al. 2022

CNS Neurosci Ther

View full text Add to dashboard Cite

show abstract

“…Alistipes has been reported as a potentially pathogenic microorganism with pro-inflammatory effects. 34,35 Studies have shown that pro-inflammatory changes in gut microbiome composition are associated with increased intestinal permeability, which is precisely the key factor in liver injury. 36 Notably, a study on the effects of ultraprocessed foods on the human gut microbiome also reported a significant increase in Alistipes abundance with ultraprocessed food intake.…”

Section: Dietary Ales Caused Hepatic Lipid Accumulation In Mice Which...mentioning

confidence: 99%

Digestibility of Malondialdehyde-Induced Dietary Advanced Lipoxidation End Products and Their Effects on Hepatic Lipid Accumulation in Mice

Wang

Zhang

Nie

et al. 2023

J. Agric. Food Chem.

View full text Add to dashboard Cite

Advanced lipoxidation end products (ALEs) are formed by modifying proteins with lipid oxidation products. The health effects of ALEs formed in vivo have been extensively studied. However, the digestibility, safety, and health risk of ALEs in heat-processed foods remain unclear. This investigation was performed to determine the structure, digestibility, and effect on the mice liver of dietary ALEs. The results showed that malondialdehyde (MDA) was able to alter the structure of myofibrillar proteins (MPs) to form linear, loop, and cross-linked types of Schiff bases and dihydropyridine derivatives under simulated heat processing, leading to the intra-and intermolecular aggregation of MPs and, thus, reducing the digestibility of MPs. In addition, dietary ALE intake resulted in abnormal liver function and lipid accumulation in mice. The core reason for these adverse effects was the destructive effect of ALEs on the intestinal barrier. Because the damage to the intestinal barrier leads to an increase in lipopolysaccharide levels in the liver, it induces liver damage by modulating hepatic lipid metabolism.

show abstract

“…In our case, Alistipes onderdonkii was overabundant in the feces of patients with SLE. This strain was recently reported as a cause of abdominal infection ( 34 ) and is reported for the first time in SLE through our study. Our results are consistent with previous studies despite the difference in the cohort size and the geographical locations of patients.…”

Section: Discussionmentioning

confidence: 52%

Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery

et al. 2022

View full text Add to dashboard Cite

An increasing number of studies have provided strong evidence that gut microbiota interact with the immune system and stimulate various mechanisms involved in the pathogenesis of auto-immune diseases such as Systemic Lupus Erythematosus (SLE). Indeed, gut microbiota could be a source of diagnostic and prognostic biomarkers but also hold the promise to discover novel therapeutic strategies. Thus far, specific SLE microbial signatures have not yet been clearly identified with alteration patterns that may vary between human and animal studies. In this study, a comparative analysis of a clinically well-characterized cohort of adult patients with SLE showed reduced biodiversity, a lower Firmicutes/Bacteroidetes (F/B) ratio, and six differentially abundant taxa compared with healthy controls. An unsupervised clustering of patients with SLE patients identified a subgroup of patients with a stronger alteration of their gut microbiota. Interestingly, this clustering was strongly correlated with the disease activity assessed with the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score (p = 0.03, odd ratio = 15) and the identification of specific alterations involving the F/B ratio and some different taxa. Then, the gut microbiota of pristane-induced lupus and control mice were analyzed for comparison with our human data. Among the six differentially abundant taxa of the human disease signature, five were common with our murine model. Finally, an exhaustive cross-species comparison between our data and previous human and murine SLE studies revealed a core-set of gut microbiome species that might constitute biomarker panels relevant for future validation studies.

show abstract

First description of abdominal infection due to Alistipes onderdonkii

Cited by 14 publications

References 11 publications

Gut bacterial profiles in Parkinson's disease: A systematic review

Gut bacterial profiles in Parkinson's disease: A systematic review

Digestibility of Malondialdehyde-Induced Dietary Advanced Lipoxidation End Products and Their Effects on Hepatic Lipid Accumulation in Mice

Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery

Contact Info

Product

Resources

About